Rampart Bioscience
Rampart Bioscience: Innovating gene therapy for lasting treatments and aiding genetically driven diseases.
Founded
2019Rampart Bioscience: Innovating gene therapy for lasting treatments and aiding genetically driven diseases.
Founded with a mission to innovate gene therapy, Rampart Bioscience develops advanced gene medicines aimed at providing long-lasting treatments for a variety of diseases. The company offers proprietary development and delivery platforms that create optimized therapeutics in a revocable, non-viral format. By integrating capabilities from gene delivery, protein sciences, and clinical translation, Rampart Bioscience focuses on assisting patients with genetically driven diseases.
Notable figures affiliated with Rampart Bioscience include leading scientists and experts in gene therapy and biotechnology. The company has attracted significant investment from prominent venture capital firms in the biotech sector. Key achievements include the development of groundbreaking gene therapy platforms that have shown promising results in preclinical studies. Rampart Bioscience's innovative approach has the potential to significantly impact the treatment landscape for genetic diseases, offering new hope to patients worldwide.
Companies similar to Rampart Bioscience include Remedium Bio, Jaguar Gene Therapy, Forge Biologics and Generation Bio.
Rampart Bioscience was founded in 2019.
Rampart Bioscience's headquarters is located in Los Angeles, CA, US.
Rampart Bioscience's most recent funding round was for $85M (USD) in October 2023.
As of Oct 24, 2023, Rampart Bioscience has disclosed funding of $85M (USD). Undisclosed round amounts are excluded.
Rampart Bioscience has 22 employees as of Feb 4, 2024.
Generation Bio
generationbio.com
